Автор: Riccardo Soffietti

Michelangelo Bartolo graduated in Medicine and specialized in Neurology at the University “La Sapienza” of Rome, and received his Ph D in Pharmacological Sciences at the University of Pavia. From 2004 to 2008 he pursued clinical research at Neurorehabilitation Unit and Laboratory of Nociceptive Psychophysiology at the IRCCS Neurological National Institute Casimiro Mondino Foundation, Pavia. Since 2008 he has conducted clinical research at the IRCCS Mediterranean Neurological Institute NEUROMED (Pozzilli, Isernia) where he was director of the Neurorehabilitation Unit. He is currently director of the Department of Rehabilitation and chief of the Neurorehabilitation Unit at the HABILITA Institute (Zingonia, Bergamo). His research interests focus on neurological rehabilitation, rehabilitation of brain tumors, neurophysiology of the motor system, and extra-pyramidal diseases. Dr. Bartolo is a member of the Italian Society of Neurology (SIN) and Vice-President of the Italian Society of Neurological Rehabilitation (SIRN); he is author of scientific publications in national and international medical journals and chapters in scientific books. Riccardo Soffietti is Professor of Neurology and Neuro-Oncology at the University of Torino and head of the Department of Neuro-Oncology at the City of Health and Science Hospital, Torino, Italy. He is the past-president of the European Association of Neuro-Oncology (EANO), chairperson of the European Academy of Neurology (EAN) Panel of Neuro-Oncology and of the World Federation of Neurology (WFN). Professor Soffietti is a member of the steering committee of the European Organization for Research of Treatment of Cancer (EORTC) Brain Tumor Group and of the International Group Response Assessment in Neuro-Oncology (RANO). Prof. Soffietti has longstanding experience in clinical and translational neuro-oncology. He has published more than 100 original papers in respected scientific journals, and many chapters in international books. Since 2015, Prof. Soffietti has been executive editor of Neuro-Oncology (OUP). He received the Award for Excellence in Clinical Research from the Society for Neuro-Oncology  (US) in 2009. Martin Klein is professor in medical neuropsychology at Amsterdam University Medical Centers,  Dept. of Medical Psychology. His research, in close cooperation with the departments of neurology, neurosurgery, and radiation oncology, initially focused on determining neurocognitive functioning and health-related quality of life of patients with brain tumors. Currently research aims at determining the brain mechanisms underlying frequent symptoms (e.g., neurocognitive deficits, epilepsy, fatigue, depression), the prevention of treatment effects on neurocognitive functioning, and on behavioral or pharmaceutical symptom treatment in primary and metastatic brain tumor patients and in oncological patients undergoing neurotoxic treatments affecting brain functioning. Dr.Klein received the Tim & Tom Gullikson Foundation and Society for Neuro-Oncology Award for Excellence in Quality of Life Research in 2001, the National Brain Tumor Foundation/Tug Mg Graw Foundation Caregiver Research Award in 2008, and the Award for Excellence of Applied Neuro-Oncology in 2017.